John C. Hartnett

Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy

B. Wesley Trotter, Kausik K. Nanda, Christopher S. Burgey et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 56 citations · Full text

Health Sciences, Functional Selectivity, Medicine +12

Synthesis of the Eight Enantiomerically Pure Diastereomers of the 12-F₂-Isoprostanes

Douglass F. Taber, Ming Xu, John C. Hartnett · Journal of the American Chemical Society · 2002 · 44 citations

Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitors

John C. Hartnett, Stanley F. Barnett, Mark T. Bilodeau et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 27 citations · Full text

Medicinal Chemistry, Akt2 Inhibitors, Biochemistry +11

Development of Pyridopyrimidines as Potent Akt1/2 Inhibitors

Zhicai Wu, John C. Hartnett, Lou Anne Neilson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 25 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +7

Crystallization and Characterization of an Esteroproteolytic Enzyme from Porcine Pancreas

Erland C. Gjessing, John C. Hartnett · Journal of Biological Chemistry · 1962 · 14 citations · Full text

Trypsin.the Activity, Biochemistry, Benzoic Acid +14